| Patient | Marie Curie |
|---|---|
| Date of birth | 1867-11-07 |
| Identifiers | MRN HR-ET013-SYN-TD; SSN (made up) 000-13-2758 |
| Document date | 1934-05-18 |
| Author | Adaeze Nwosu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Hematology consultation for pancytopenia, with bone marrow aspirate and biopsy. [S]
Madame Curie is seen in hematology one week after her primary care visit, where two months of fatigue, breathlessness on stairs, easy bruising, and a recent fever led to a blood count showing pancytopenia with a low reticulocyte count. She received two units of irradiated red cells that day. She is less breathless since the transfusion but still tires by midafternoon. New bruises appear on her arms and shins without injury; she has had no nosebleeds, gum bleeding, blood in the urine or stool, or further fever. She has worked for decades with radium sources and X-ray equipment, much of it before modern shielding, and she has stopped laboratory work since the last visit. She wants the data and the plan in detail. [S]
| Element | Detail |
|---|---|
| Since the transfusion | Less breathless; fatigue by midafternoon |
| Bleeding | Bruises on arms and shins without injury; no mucosal, urinary, or bowel bleeding |
| Infection | No fever since the first visit |
| Exposure | Decades of occupational ionizing radiation; no further exposure since the first visit |
| Patient preference | Wants the full data and plan |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue by midafternoon; no fever, night sweats, or weight loss |
| Hematologic | Positive | Easy bruising; no mucosal bleeding |
| Cardiovascular | Positive | Breathless on stairs, better since transfusion; no chest pain |
| Eyes | Positive | Glare and blurred reading vision in the right eye |
| Skin | Positive | Thin, scarred fingertips; no rash |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyclosporine (modified) 100 mg oral capsule, one capsule twice daily, dose adjusted to trough levels by hematology | One capsule by mouth twice daily; hematology adjusts the dose to trough levels | Oral route | 1934-05-18 | active | S |
| Eltrombopag 75 mg oral tablet, two tablets (150 mg) once daily on an empty stomach | Two tablets by mouth once daily, two hours before or four hours after food, dairy, or antacids | Oral route | 1934-05-18 | active | S |
| Acyclovir 400 mg oral tablet, one tablet twice daily during immunosuppression | One tablet by mouth twice daily | Oral route | 1934-05-18 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1934-05-18 | Body height | 157 | cm | S |
| 1934-05-18 | Body weight | 51 | kg | S |
| 1934-05-18 | Body mass index (BMI) [Ratio] | 20.7 | kg/m2 | S |
| 1934-05-18 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1934-05-18 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1934-05-18 | Heart rate | 92 | /min | S |
| 1934-05-18 | Respiratory rate | 16 | /min | S |
| 1934-05-18 | Body temperature | 36.9 | Cel | S |
| 1934-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1934-05-18 | Hemoglobin [Mass/volume] in Blood | 8.9 | g/dL | 11.6-15 g/dL | Low | S |
| 1934-05-18 | Leukocytes [#/volume] in Blood by Automated count | 1.8 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 1934-05-18 | Neutrophils [#/volume] in Blood by Automated count | 0.4 | 10*3/uL | 1.5-7.5 10*3/uL | Low | S |
| 1934-05-18 | Platelets [#/volume] in Blood by Automated count | 15 | 10*3/uL | 150-400 10*3/uL | Low | S |
| 1934-05-18 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 | fL | 80-100 fL | High | S |
| 1934-05-18 | Reticulocytes [#/volume] in Blood by Automated count | 12 | 10*3/uL | 25-100 10*3/uL | Low | S |
Vital signs recorded on 1934-05-18; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Pale, alert, precise, and composed |
| Skin | Scattered bruises on the forearms and shins; a few petechiae on the lower legs; thin, scarred fingertip skin |
| Mouth | No gum bleeding or blood blisters; no ulcers |
| Lymph nodes | No lymphadenopathy |
| Abdomen | No hepatomegaly or splenomegaly |
| Heart | Regular rhythm, pulse 92; soft flow murmur |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Severe aplastic anemia: pancytopenia with a low reticulocyte count, confirmed by a hypocellular bone marrow; attributed to cumulative occupational ionizing radiation; linked to the documented 1842 diagnosis | active | confirmed | D61.2 | S — Synthetic modern diagnosis; the 1934 report remains D and the radiation cause is R. |
| Occupational exposure to ionizing radiation over decades of radium research and X-ray work | active | confirmed | Z57.1 | S — Synthetic modern coding of the documented exposure history. |
| Chronic radiodermatitis of the fingertips, with thin, scarred skin | active | confirmed | L58.1 | S — Synthetic skin finding linked to the documented finger burns. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | CBC with differential and reticulocyte count | Weekly during the first months of treatment | Completed today | Before treatment: hemoglobin 8.9 g/dL after transfusion, white cells 1.8, neutrophils 0.4, platelets 15, reticulocytes 12 thousand per microliter, MCV 101 fL |
| Laboratory | Bone marrow aspirate and trephine biopsy with cytogenetics | At diagnosis | Completed today | About 10 percent cellularity; no dysplasia, fibrosis, or malignant cells; normal cytogenetics, excluding hypoplastic myelodysplasia |
| Laboratory | PNH clone by flow cytometry | At diagnosis | Completed today | No PNH clone |
| Laboratory | Kidney function and potassium before cyclosporine | Before starting | Up to date | One week ago: creatinine 0.78 mg/dL, eGFR 84, potassium 4.1 |
| Laboratory | Liver tests (ALT) before eltrombopag | Before starting | Deferred | No ALT is on record before eltrombopag started today; bilirubin was 0.6 mg/dL a week ago. A deviation from the protocol. Corrective action: ALT with the next blood draw |
| Laboratory | Viral serology before immunosuppression (hepatitis B, hepatitis C, HIV, CMV, EBV) | At diagnosis, before immunosuppression | Deferred | No results are in this record before treatment started, a deviation from the protocol. Corrective action: flagged to hematology to send with the next blood draw |
| Laboratory | Cyclosporine trough level | Regularly from the first weeks of treatment, to guide the dose | Due | Cyclosporine starts today; first level due within the first weeks |
| Medication safety | Antiviral prophylaxis during immunosuppression | From the start of antithymocyte globulin | Completed today | Acyclovir 400 mg twice daily started |
| Medication safety | Antibacterial and antifungal prophylaxis while severely neutropenic | While neutrophils are below 0.5 thousand per microliter, by local policy | Deferred | Neutrophils 0.4. Not prescribed today; the guideline leaves agent and threshold to local policy. Recorded as a gap for hematology to confirm; same-day fever plan in place |
| Medication safety | Pneumocystis prophylaxis | Not routinely required with this regimen | Not indicated | Not started |
| Medication safety | Irradiated, leukocyte-depleted blood products | From antithymocyte globulin onward | Completed today | Blood bank flag placed |
| Examination | Blood pressure and weight on cyclosporine | Every visit | Completed today | 116/70 mmHg, weight 51 kg before cyclosporine |
| Self-management | Same-day assessment for a temperature of 38 °C or higher; bleeding precautions; no aspirin or NSAIDs | Every visit | Completed today | Written plan given; thermometer at home |
| Self-management | No further occupational radiation exposure | While counts recover | Completed today | Away from the laboratory since the first visit |
| Examination | Comprehensive dilated eye examination with functional vision assessment | Every 1 to 2 years at 65 or older, and when symptoms limit daily tasks | Due | Right-eye glare noted; review at the next primary care visit |
Goal progress:
Guideline basis: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024); CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026)
Follow-up: Antithymocyte globulin course in the hematology unit this week. Weekly blood counts. Primary care review in three weeks with blood counts, kidney function, potassium, ALT, and an eye review. Next scheduled visit 1934-06-08: primary care follow-up three weeks after starting immunosuppressive therapy, with a cataract and eye review. [S]